Stock screener

ANIP

Conviction 65HealthcareScan · Thu, Jun 25, 2026
ANIP$83.24+0.63%
ResistanceSupportVol 14Insider sell
63 bars
2
2
2
Vol MA14 332.53K
Mar 26Apr 14May 1May 19Jun 8Jun 25
ANI PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.anipharmaceuticals.com
Price83.24
Change+0.63%
Gap+0.81%
Rel volume2.48×
Avg volume337.92K
Avg $ vol27.19M
SMA 2080.39
SMA 5080.43
SMA 20082.80
Price vs 50+3.49%
Price vs 200+0.53%
MA stackmixed
50/200 cross
Supertrendup · 75.87
RSI (14)58
MACD hist0.24
MACD cross
Stoch %K / %D80 / 85
ADX (14)13
+DI / −DI25 / 18
RSI divergence
MACD divergence
ATR %+3.10%
ADR %3.07%
52w high98.81
52w low63.35
From 52w high-15.76%
Above 52w low+31.40%
New 52w highNo
SqueezeOff
Bollinger width12.01%
%B0.80
Donchian pos88.75%
Donchian high84.47
Donchian low73.54
AVWAP (52w high)82.60
vs AVWAP high+0.78%
AVWAP (52w low)83.20
vs AVWAP low+0.05%
OBV trendUp
Chaikin MF (20)-0.11
Today vs 20d2.48×
Avg vol (14d)332.53K
Avg vol (20d)337.92K
Avg $ vol (20d)27.19M
Market cap2.03B
RS 3m (vs SPY)+0.58%
RS 6m (vs SPY)-7.89%
RS line new highNo
Trend template5/8
Technical rank58.4
1 week+3.38%
1 month+2.25%
3 months+12.38%
6 months+3.12%
1 year+24.28%
YTD+6.13%
P/E25.95
P/B3.62
P/S2.30
P/FCF11.86
EPS3.32
Div yield0.06%
ROE13.93%
ROA5.51%
Debt/Eq0.54
Current3.12
EV/EBITDA12.80
Gross margin
Net margin8.87%
Rev growth43.78%
EPS growth522.94%
Price target114.00
Target upside36.95%
Analyst ratingBuy
Institutional109.14%
Ent. value2.03B
Revenue237.46M
Net income29.49M
Gross profit
Free cash flow171.39M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out22.73M
Employees970
ListedMon, Sep 13, 1999
Free float19.39M
Float %85.2%
Short interest3.32M
Days to cover9.9d
Short volume58.7%
Squeeze score87 / 100
Next earnings
EPS forecast
Last EPS vs est$1.68 vs $0.96
Last surprise+75.0% beat
Setup gradeB
Conviction65 / 100
Pattern quality
Tech rank58.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance85.86
Support74.83
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANIP

All disclosures →
No recent disclosed trades by Congress in ANIP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANIP · 6 buys · 4 sells

InsiderSideShares
HAUGHEY THOMAS
Director · Common Stock · 2026-06-08
Sell2K
TANNENBAUM RENEE P
Director · Common Stock · 2026-05-21
Grant4.36K
HAUGHEY THOMAS
Director · Common Stock · 2026-05-21
Grant4.36K
Pera Antonio R
Director · Common Stock · 2026-05-21
Grant4.36K
Leonard Matthew J
Director · Common Stock · 2026-05-21
Grant4.36K
Thoma Jeanne
Director · Common Stock · 2026-05-21
Grant4.36K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-06-05
Sell3.31K
CAREY STEPHEN P.
SVP & CFO · Common Stock · 2026-06-05
Exercise3.31K
CAREY STEPHEN P.
SVP & CFO · Stock Option (right to buy) · 2026-06-05
Exercise3.31K
Walsh Patrick D
Director · Common Stock · 2026-05-13
Sell10K

SEC filings

EDGAR filings in ANIP · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.